Integral Diagnostics Limited
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as … Read more
Market Cap & Net Worth: Integral Diagnostics Limited (ITGDF)
Integral Diagnostics Limited (PINK:ITGDF) has a market capitalization of $783.15 Million ($783.15 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #11744 globally and #5185 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Integral Diagnostics Limited's stock price $2.10 by its total outstanding shares 372926663 (372.93 Million).
Integral Diagnostics Limited Market Cap History: 2023 to 2025
Integral Diagnostics Limited's market capitalization history from 2023 to 2025. Data shows growth from $725.60 Million to $783.15 Million (0.08% CAGR).
Integral Diagnostics Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Integral Diagnostics Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.25x
Integral Diagnostics Limited's market cap is 1.25 times its annual revenue
0.69x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
167.59x
Integral Diagnostics Limited's market cap is 167.59 times its annual earnings
363.13x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $725.60 Million | $440.10 Million | $25.04 Million | 1.65x | 28.98x |
| 2024 | $783.15 Million | $469.70 Million | -$60.70 Million | 1.67x | N/A |
| 2025 | $783.15 Million | $627.22 Million | $4.67 Million | 1.25x | 167.59x |
Competitor Companies of ITGDF by Market Capitalization
Companies near Integral Diagnostics Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Integral Diagnostics Limited by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Integral Diagnostics Limited Historical Marketcap From 2023 to 2025
Between 2023 and today, Integral Diagnostics Limited's market cap moved from $725.60 Million to $ 783.15 Million, with a yearly change of 0.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $783.15 Million | 0.00% |
| 2024 | $783.15 Million | +7.93% |
| 2023 | $725.60 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Integral Diagnostics Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $783.15 Million USD |
| MoneyControl | $783.15 Million USD |
| MarketWatch | $783.15 Million USD |
| marketcap.company | $783.15 Million USD |
| Reuters | $783.15 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.